Lehrstuhl für Genetik

A novel strain-specific neutralizing epitope on glycoprotein H of human cytomegalovirus (2021) Thomas M, Kropff B, Schneider A, Winkler T, Görzer I, Sticht H, Britt WJ, et al. Journal article, Original article The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies (2021) Monnet C, Jacque E, de Romeuf C, Fontayne A, Abache T, Fournier N, Dupont G, et al. Journal article Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections (2021) Szumilas N, Corneth OB, Lehmann C, Schmitt H, Cunz S, Cullen JG, Chu T, et al. Journal article Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice (2021) Rip J, De Bruijn MJW, Neys SFH, Singh SP, Willar J, Van Hulst JAC, Hendriks RW, Corneth OBJ Journal article Cd22 controls germinal center b cell receptor signaling, which influences plasma cell and memory b cell output (2021) Meyer SJ, Steffensen M, Acs A, Weisenburger T, Wadewitz C, Winkler T, Nitschke L Journal article A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model (2021) Peter AS, Roth E, Schulz S, Fraedrich K, Steinmetz T, Damm D, Hauke M, et al. Journal article, Original article A novel orthotopic TCR transgenic mouse model dissects the role of antigen receptor specificity for.d T cell development and function (2021) Hahn AM, Schneider A, Brey S, Vogg L, Schäfer S, Winkler T Conference contribution There Is strength in numbers - episode 2: a comprehensive quantitation of Fc gamma receptors on murine tissue-resident macrophages (2021) Friedrich N, Vorsatz C, Nimmerjahn F, Biburger M Conference contribution On the loss of inhibitory function due to FcgRIIB-I232T transmembrane polymorphism (2021) Pöhnl M, Nimmerjahn F, Böckmann R Conference contribution Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy (2021) Klausz K, Cieker M, Kellner C, Roesner T, Otte A, Krohn S, Lux A, et al. Journal article